IBD and IPF Disease Models at MLM Medical Labs

When Inflammation Travels: Exploring the Link Between IBD and IPF

A mid-sized biopharmaceutical company planning a global Phase II immuno-oncology trial in advanced solid tumors would face a critical operational challenge: ensuring consistent, high-quality PBMC processing across diverse geographies. PBMC-based immune monitoring is central to their biomarker strategy, but coordinating this across five continents introduces scientific and logistical risks.
This Applied Insights Brief outlines the likely challenges such a sponsor would encounter, how MLM Medical Labs would structure a tailored solution, and the measurable outcomes sponsors could expect by partnering with MLM.

When Inflammation Travels: Exploring the Link Between IBD and IPF Read More »

CAIA and CIA preclinical models

Beyond Inflammation: How Advanced Arthritis Models Help Us Stay Active and Pain-Free This Summer

A mid-sized biopharmaceutical company planning a global Phase II immuno-oncology trial in advanced solid tumors would face a critical operational challenge: ensuring consistent, high-quality PBMC processing across diverse geographies. PBMC-based immune monitoring is central to their biomarker strategy, but coordinating this across five continents introduces scientific and logistical risks.
This Applied Insights Brief outlines the likely challenges such a sponsor would encounter, how MLM Medical Labs would structure a tailored solution, and the measurable outcomes sponsors could expect by partnering with MLM.

Beyond Inflammation: How Advanced Arthritis Models Help Us Stay Active and Pain-Free This Summer Read More »

Reframing Fibrosis in Systemic Sclerosis: A Focus on Neutrophil–Macrophage Dynamics

A mid-sized biopharmaceutical company planning a global Phase II immuno-oncology trial in advanced solid tumors would face a critical operational challenge: ensuring consistent, high-quality PBMC processing across diverse geographies. PBMC-based immune monitoring is central to their biomarker strategy, but coordinating this across five continents introduces scientific and logistical risks.
This Applied Insights Brief outlines the likely challenges such a sponsor would encounter, how MLM Medical Labs would structure a tailored solution, and the measurable outcomes sponsors could expect by partnering with MLM.

Reframing Fibrosis in Systemic Sclerosis: A Focus on Neutrophil–Macrophage Dynamics Read More »

CD4/CD8 Duplex Immunofluorescence

CD4/CD8 Duplex Immunofluorescence : High-Resolution Immune Profiling from a Single Slide

A mid-sized biopharmaceutical company planning a global Phase II immuno-oncology trial in advanced solid tumors would face a critical operational challenge: ensuring consistent, high-quality PBMC processing across diverse geographies. PBMC-based immune monitoring is central to their biomarker strategy, but coordinating this across five continents introduces scientific and logistical risks.
This Applied Insights Brief outlines the likely challenges such a sponsor would encounter, how MLM Medical Labs would structure a tailored solution, and the measurable outcomes sponsors could expect by partnering with MLM.

CD4/CD8 Duplex Immunofluorescence : High-Resolution Immune Profiling from a Single Slide Read More »

LPS-induced acture lung injury modell

Targeting the IRE1α-XBP1 Axis: A Novel Approach in ALI Treatment

A mid-sized biopharmaceutical company planning a global Phase II immuno-oncology trial in advanced solid tumors would face a critical operational challenge: ensuring consistent, high-quality PBMC processing across diverse geographies. PBMC-based immune monitoring is central to their biomarker strategy, but coordinating this across five continents introduces scientific and logistical risks.
This Applied Insights Brief outlines the likely challenges such a sponsor would encounter, how MLM Medical Labs would structure a tailored solution, and the measurable outcomes sponsors could expect by partnering with MLM.

Targeting the IRE1α-XBP1 Axis: A Novel Approach in ALI Treatment Read More »

Global PBMC isolations, processing and analyses

Managing PBMC Complexity in Global Immuno-Oncology Trials

A mid-sized biopharmaceutical company planning a global Phase II immuno-oncology trial in advanced solid tumors would face a critical operational challenge: ensuring consistent, high-quality PBMC processing across diverse geographies. PBMC-based immune monitoring is central to their biomarker strategy, but coordinating this across five continents introduces scientific and logistical risks.
This Applied Insights Brief outlines the likely challenges such a sponsor would encounter, how MLM Medical Labs would structure a tailored solution, and the measurable outcomes sponsors could expect by partnering with MLM.

Managing PBMC Complexity in Global Immuno-Oncology Trials Read More »

Customized preclinical models for rare disease drug discovery research

Pioneering Solutions in Rare Disease Research: MLM Medical Labs’ Customized Preclinical Models

Pioneering Solutions in Rare Disease Research:MLM Medical Labs’ Customized Preclinical Models by Katie Dineen, B.S., Business Development Manager Preclinical Laboratory Services  Rare diseases collectively impact over 300 million people worldwide, yet for many, effective treatments remain elusive. With more than 7,000 identified rare diseases, the challenge is not only in developing targeted therapies but also

Pioneering Solutions in Rare Disease Research: MLM Medical Labs’ Customized Preclinical Models Read More »

Obesity and 2025 Metabolic Research at MLM Medical Labs

Love Your Research, Love Healthy Bodies: Advancing Obesity and Metabolic Health Research

Love Your Research, Love Healthy Bodies: Advancing Obesity and Metabolic Health Research by Katie Dineen, B.S., Business Development Manager Preclinical Laboratory Services Valentine’s Day is a time to celebrate love, care, and well-being—not just for each other, but also for the health of our bodies. At MLM Medical Labs, we are dedicated to supporting research

Love Your Research, Love Healthy Bodies: Advancing Obesity and Metabolic Health Research Read More »

Real-time clinical trial data and sample inventory

Clinical Trial Data Control plus Sample Inventory at Your Fingertips: Introducing mlm online® plus

Data Control and Sample Inventory at Your Fingertips: Introducing mlm online® and mlm online® plus In today’s fast-paced clinical trial environment, having real-time access to clinical data is not just a convenience—it’s essential. For study physicians, nurses, CROs, and sponsors, rapid and secure data access can mean the difference between staying on track and costly

Clinical Trial Data Control plus Sample Inventory at Your Fingertips: Introducing mlm online® plus Read More »